MUDHRA Cohort, Based in Mysore, South India, Begins Work with Davos Alzheimer's Collaborative

MUDHRA Cohort, Based in Mysore, South India, Begins Work with Davos Alzheimer’s Collaborative

#MUDHRA #Cohort #Based #Mysore #South #India #Begins #Work #Davos #Alzheimers #Collaborative

We started studying the determinants of health in Mysore in 2006 and now we have a rich repository of historical data providing information on the health of Indians living in rural areas.

— Dr. Murali Krishna, Assistant Professor at JSS Medical College and JSS Academy

DAVOS, SWITZERLAND, June 2, 2022 / — Today, the Davos Alzheimer’s Collaboration (DAC) announces that the Mysuru Studies of Determinants of Health in Rural Adults cohort ( MUDHRA) based in Mysore, South India, is working with the CAD Global Cohort Development program, an innovative data platform to accelerate the discovery, evaluation and delivery of precision interventions for Alzheimer’s disease.

The DAC Global Cohort Development (GCD) platform will help drive scientific discovery by providing researchers with access to an expansive and truly international platform filled with brain health data from large and diverse populations. It will support AI and machine learning with curated and aggregated data collected from digital devices in research labs, hospitals, and even people’s smartphones. This data resource will help determine the causes, predispositions, and habits of people who develop Alzheimer’s disease. It can also inform drug discovery and clinical care at a faster rate.

MUDHRA is a well-established population-based cohort that was established in 2006 with participants from rural areas of Mysore district in South India to examine the burden of lung disorders and their impact on physical and mental health and quality of life. . This cohort was created by Prof. Mahesh PA, Department of Pulmonology, JSS Medical College, Mysore. Cohort members have been screened for chronic bronchitis, COPD, depression, and vitamin D deficiency. They are currently undergoing repeated assessments of lung function, exposure to environmental pollutants, and cognitive function.

“When we started this work, our focus was to look at the data between biofuel smoke exposure and diagnosis of chronic bronchitis and COPD,” said Dr. Murali Krishna of Mental Health Defense and Research Foundation, Mysuru, India, and Associate Professor . , Department of Psychiatry, JSS Medical College and Hospital and JSS Academy of Higher Education and Research, Mysuru, India. “We now have a rich repository of historical data that provides information on the health of Indians living in rural areas.

“Collaboration and inclusion are key to beating Alzheimer’s disease,” said Dr. Rhoda Au, director of global cohort development at DAC. “Working in silos with a limited representation of participants from around the world does not produce results, neither comprehensive enough nor fast enough. Previous studies have biased the results due to the exclusion of low- and middle-income areas and/or countries. We believe that the important work and scientific evidence from the Mysuru studies on the determinants of health in rural adults will improve our understanding of Alzheimer’s disease. »

Global Cohort Development combines the best of science: collaboration, creative thinking, and discovery. Other interested researchers whose cohorts share these goals are encouraged to apply. Due to the synergistic nature of this work, cohorts with limited resources are put on an equal footing with large research organizations. Supporters see the show as a cost-effective way to influence important new ideas needed to stem the tide of Alzheimer’s disease.

About the Davos Alzheimer Collaboration
Launched in Davos, Switzerland, at the World Economic Forum annual meeting in 2020, The Davos Alzheimer’s Collaborative is a public-private partnership committed to aligning stakeholders around a new vision for our collective global response to the challenges of Alzheimer’s. Alzheimer disease. health infrastructure. Led by the World Economic Forum (WEF) and the Global CEO Initiative on Alzheimer’s Disease (CEOi) and driven by a mission to serve the 150 million families and 500 million people inevitably affected by this disease by 2050, DAC is a collaborative for the benefit of everyone, everywhere.

pat arcand
Davos Alzheimer Collaborative GCD
+1 617-251-7778
[email protected]

Leave a Comment

Your email address will not be published. Required fields are marked *